Overview

A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study will determine whether BOLD-fMRI can be used to probe hunger and satiety states in healthy overweight or obese men and also whether fasted/fed fMRI signals can be modulated by sibutramine.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Sibutramine